Log in to your Inderes Free account to see all free content on this page.

Faron Pharmaceuticals

0.48 EUR

-0.62%

5,705 following
Corporate customer

FARON

First North Finland

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Faron Pharmaceuticals

Dividend yield

Median 2021-2025

P/B

Median 2021-2025

 
20192020202120222023202420252026e2027e2028e2029e
Share price (EUR)3.302.913.243.713.772.242.450.480.480.480.48
Shares43.346.953.259.868.8104.6118.6222.8246.1265.5265.5
Market cap142.9136.5172.5221.6259.3234.4290.5107.6118.9128.2128.2
Enterprise value138.2135.1169.0227.5265.3236.7302.6102.4130.4156.2168.4
EV/S34,556.033,775.442,241.456,880.566,337.259,166.275,657.025,596.032,609.639,043.1159.9
EV/EBITDAneg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
EV/EBIT (adj.)neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
EV/EBITneg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
P/E (adj.)neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
P/Eneg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
P/B88.7neg.58.8neg.neg.neg.neg.83.8neg.neg.neg.
P/S35,714.334,117.343,117.955,389.864,831.558,589.472,618.026,905.529,721.432,054.3121.8
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio15.8 %-22.1 %22.3 %-101.8 %-148.4 %-78.0 %-107.8 %3.3 %-133.4 %-523.3 %-615.2 %
Gearing ratio-287.8 %73.9 %-119.5 %-52.0 %-39.7 %-23.6 %-65.7 %-407.9 %-73.5 %-86.6 %-85.4 %
Login required

This content is only available for logged in users